SERNA, I. M. R., I. ROMITO, A. MAUGERI, Oriana LO RE, Sebastiano GIALLONGO, G. MAZZOCCOLI, J. A. OBEN, G. LI VOLTI, T. MAZZA, A. ALISI a Manlio VINCIGUERRA. A Lipidomic Signature Complements Stemness Features Acquisition in Liver Cancer Cells. International Journal of Molecular Sciences. Basel: Multidisciplinary Digital Publishing Institute, 2020, roč. 21, č. 22, s. 1-17. ISSN 1422-0067. Dostupné z: https://dx.doi.org/10.3390/ijms21228452.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název A Lipidomic Signature Complements Stemness Features Acquisition in Liver Cancer Cells
Autoři SERNA, I. M. R., I. ROMITO, A. MAUGERI, Oriana LO RE (380 Itálie), Sebastiano GIALLONGO (380 Itálie, domácí), G. MAZZOCCOLI, J. A. OBEN, G. LI VOLTI, T. MAZZA, A. ALISI a Manlio VINCIGUERRA (380 Itálie, garant).
Vydání International Journal of Molecular Sciences, Basel, Multidisciplinary Digital Publishing Institute, 2020, 1422-0067.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 10608 Biochemistry and molecular biology
Stát vydavatele Švýcarsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 5.923
Kód RIV RIV/00216224:14110/20:00117463
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.3390/ijms21228452
UT WoS 000594195100001
Klíčová slova anglicky FAK; HCC; stemness; cancer stem cells
Štítky 14110513, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 21. 7. 2021 10:27.
Anotace
Lipid catabolism and anabolism changes play a role in stemness acquisition by cancer cells, and cancer stem cells (CSCs) are particularly dependent on the activity of the enzymes involved in these processes. Lipidomic changes could play a role in CSCs' ability to cause disease relapse and chemoresistance. The exploration of lipid composition and metabolism changes in CSCs in the context of hepatocellular cancer (HCC) is still incomplete and their lipidomic scenario continues to be elusive. We aimed to evaluate through high-throughput mass spectrometry (MS)-based lipidomics the levels of the members of the six major classes of sphingolipids and phospholipids in two HCC cell lines (HepG2 and Huh-7) silenced for the expression of histone variant macroH2A1 (favoring stemness acquisition), or silenced for the expression of focal adhesion tyrosine kinase (FAK) (hindering aggressiveness and stemness). Transcriptomic changes were evaluated by RNA sequencing as well. We found definite lipidomic and transcriptomic changes in the HCC lines upon knockdown (KD) of macroH2A1 or FAK, in line with the acquisition or loss of stemness features. In particular, macroH2A1 KD increased total sphingomyelin (SM) levels and decreased total lysophosphatidylcholine (LPC) levels, while FAK KD decreased total phosphatidylcholine (PC) levels. In conclusion, in HCC cell lines knocked down for specific signaling/epigenetic processes driving opposite stemness potential, we defined a lipidomic signature that hallmarks hepatic CSCs to be exploited for therapeutic strategies.
VytisknoutZobrazeno: 18. 7. 2024 20:20